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The elevated uric acid level (hyperuricemia) occur in 5% 
of the general population and most of them are 
asymptomatic.1 Since 1963, allopurinol has been 
introduced and widely using to reduce the uric acid 
level.2 In vivo, allopurinol converts into oxypurinol 
which serves as xanthine analog and combine with 
xanthine oxydase enzyme, which intern prevents the 
formation of uric acid in the body.3 Although, allopurinol 
is generally well tolerated, life-threatening toxic effects 
have been reported from different regions.1,2,4,5 
Erythroderma alternatively termed as generalized 
exfoliative dermatitis is one of the adverse reactions 
triggered by allopurinol.  
Erythroderma is a scaly, erythematous dermatitis that 
involves at least 90% of the surface of the skin. It is a rare 
disease, and its occurrence might be closely linked to:  
1. Drug use such as allopurinol, carbamazepine, 
phenytoin  
ABSTRACT 
Erythroderma is a scaly, erythematous dermatitis of the skin, which occurs in 
drug allergy, malignancy and underlying skin disorders. The diagnosis is 
challenging because the extent of skin involvement does not always correlate 
with the extent of internal organ involvement. Therefore, early recognition of 
symptoms is vital to minimize morbidity and mortality. Case report: A 52 years 
old man had asymptomatic hyperuricemia and prescribed allopurinol 300mg, 
daily. One month later, the rashes started to appear on his trunk and then 
progressed to the face and upper limbs. Then it continued to spread to the lower 
extremities. Management involves prompt cessation of the culprit drug, 
administration of corticosteroids and supportive treatment. It is Concluded that 
Allopurinol is commonly used in clinical practice for the treatment of 
symptomatic hyperuricemia and gout. It has been associated with erythroderma 
especially when used indiscriminately. 
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